Alexandra Snyder

Alexandra Snyder,MD, is a translational physician scientist at Memorial Sloan Kettering Cancer Center (MSKCC) who specializes in the study of tumor genetics and response to checkpoint blockade immunotherapy in solid tumors, with a particular focus on ovarian cancer.  Dr. Snyder received her medical degree at the Mount Sinai School of Medicine.  She completed internal medicine training at Mount Sinai Hospital and medical oncology fellowship at MSKCC, where she was Chief Fellow.  She is now an Assistant Attending on the Gynecologic Medical Oncology and Immunotherapeutics services at MSKCC.  Her prior studies, published in the New England Journal of Medicine and Science highlighted the correlation between elevated mutation and neoantigen burden and clinical benefit from checkpoint blockade therapies.  Her current work extends these methodologies to provide an integrated understanding of the tumor and tumor microenvironment.  Her long-term goal is to combine conventional and immune therapies in ovarian cancer in order to permit disease control by the immune system, with decreased toxicity and increased survival.